However, since tumor antigen-specific antibodies can contribute to the antitumor effect in several different ways, such as antibody-dependent cytotoxicity and phagocytosis of opsonized tumor cells [45], we do not rule out the potential involvement of HER2-specific antibodies in the antitumor effect of BVAC-K1117. The gene discussed is ERBB2; the disease is neoplasm.